Impact News +++ Castle Biosciences Reports Third Quarter 2025 Results (GlobeNewswire EN) +++ CASTLE BIOSCIENCES Aktie -3,00%

CASTLE BIOSCIENCES Aktie

>CASTLE BIO Aktienkurs

22.6 EUR (Tradegate)

Ask: 22.8 EUR / 880 Stück

Bid: 22.4 EUR / 900 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

CASTLE BIO Aktie über LYNX handeln

Intraday

1 Jahr

>CASTLE BIO Performance

1 Woche: +8,1%

1 Monat: +17,1%

3 Monate: 0%

6 Monate: 0%

1 Jahr: 0%

laufendes Jahr: 0%

>CASTLE BIOSCIENCES Aktie

Name:

CASTLE BIOSCIENCES

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US14843C1053 / A2PNH3

Symbol/ Ticker:

086 (Frankfurt) / CSTL (NASDAQ)

Kürzel:

FRA:086, ETR:086, 086:GR, NASDAQ:CSTL

Index:

Webseite:

https://castlebiosciences..

Profil:

Castle Biosciences, Inc. is a **molecular diagnost..
>Volltext..

Marktkapitalisierung:

642.17 Mio. EUR

Unternehmenswert:

435.05 Mio. EUR

Umsatz:

300.61 Mio. EUR

EBITDA:

16.87 Mio. EUR

Nettogewinn:

-8.22 Mio. EUR

Gewinn je Aktie:

-0.28 EUR

Schulden:

32.43 Mio. EUR

Liquide Mittel:

71.39 Mio. EUR

Operativer Cashflow:

60.05 Mio. EUR

Bargeldquote:

5.42

Umsatzwachstum:

20.4%

Gewinnwachstum:

-205.45%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

1 Insider verkaufte innerhalb der letzten 30 Tage Aktien im Wert von 60.282 USD.

Suchwörter:

CASTLE BIOSCIENCES, CASTLE BIO, CASTLE BIOSCIENCE

Letzte Datenerhebung:

04.11.25

>CASTLE BIO Kennzahlen

Aktien/ Unternehmen:

Aktien: 29.01 Mio. St.

Frei handelbar: 97.14%

Leerverk. Aktien: 5.54%

Rückkaufquote: -0.27%

Mitarbeiter: 761

Umsatz/Mitarb.: 0.38 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 39.71%

Bewertung:

KGV: -

KGV lG: -

KUV: 2.07

KBV: 1.62

PEG-Ratio: -0.41

EV/EBITDA: 25.78

Rentabilität:

Bruttomarge: 69.73%

Gewinnmarge: -2.73%

Operative Marge: -6.66%

Managementeffizenz:

Gesamtkaprendite: -1.83%

Eigenkaprendite: -2.15%

>CASTLE BIO Peer Group

Es sind 597 Aktien bekannt.

>CASTLE BIO Chart & Kurs - NASDAQ

>CASTLE BIO News

03.11.25 - 23:54	Earnings Call Transkript: Castle Biosciences übertrifft Umsatzprognose für Q3 2025 und hebt Ausblick an (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

03.11.25 - 22:09	Castle Biosciences Reports Third Quarter 2025 Results (GlobeNewswire EN)
	Castle Biosciences, Inc. (Nasdaq: CSTL) today announced its financial results for the third quarter and nine months ended Sept. 30, 2025....

31.10.25 - 20:36	A Glimpse of Castle Biosciences′s Earnings Potential (Benzinga)
	read more...

31.10.25 - 09:45	Zacks.com featured highlights include RadNet, Mission Produce, Castle Biosciences and FreightCar America (Zacks)
	RadNet, Mission Produce, Castle Biosciences, and FreightCar America stand out for rising cash flows amid profit-focused markets....

30.10.25 - 18:45	Forget Profit, Pick These 4 Stocks With Increasing Cash Flows (Zacks)
	Amid earnings buzz, stocks like RadNet, Mission Produce, Castle Biosciences and FreightCar America stand out for their rising cash flows and resilience....

28.10.25 - 12:03	Castle Biosciences to Participate in Upcoming Investor Conferences (GlobeNewswire EN)
	Castle Biosciences to Participate in November Investor Conferences...

27.10.25 - 16:30	Analysts Estimate Castle Biosciences, Inc. (CSTL) to Report a Decline in Earnings: What to Look Out for (Zacks)
	Castle Biosciences (CSTL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

23.10.25 - 19:01	Insiderhandel: Pres. & Chief Exec. Officer verkauft Aktien von Castle Biosciences im Wert von 30047 USD (Insiderkauf)
	Maetzold, Derek J. - Vorstand - Tag der Transaktion: 2025-10-20...

22.10.25 - 08:18	Nomination Committee appointed for SciBase Holding′s Annual General Meeting in 2026 (PR Newswire)
	STOCKHOLM, Oct. 22, 2025 /PRNewswire/ -- The following people have been appointed as members of SciBase Holding's nominating committee for the Annual General Meeting in 2026: Anders Bladh (Ribbskottet AB), Derek Maetzold (Castle Biosciences Inc) Maria Anderkvist (Coeli Wealth Management),......

21.10.25 - 19:45	What Makes Castle Biosciences (CSTL) a New Strong Buy Stock (Zacks)
	Castle Biosciences (CSTL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

13.10.25 - 13:03	Castle Biosciences to Release Third Quarter 2025 Financial Results and Host Conference Call on Monday, Nov. 3, 2025 (GlobeNewswire EN)
	Castle Biosciences will release Q3 2025 financial results and host conference call on Monday, Nov. 3, 2025...

06.10.25 - 23:01	Insiderhandel: Pres. & Chief Exec. Officer verkauft Aktien von Castle Biosciences im Wert von 30235 USD (Insiderkauf)
	Maetzold, Derek J. - Vorstand - Tag der Transaktion: 2025-10-02...

01.10.25 - 22:33	Castle Biosciences′ Founder, President and CEO Derek Maetzold Honored with the CEO of the Year Award by The CEO Magazine (GlobeNewswire EN)
	Castle Biosciences' Founder, President & CEO Derek Maetzold awarded CEO of the Year by The CEO Magazine...

24.09.25 - 04:00	SciBase receives initial order for clinical study from Castle Biosciences (ShareCast)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

23.09.25 - 13:03	Castle Biosciences Honored with a Greater Pittsburgh Top Workplaces 2025 Award (GlobeNewswire EN)
	Castle Biosciences has been recognized as a Greater Pittsburgh Top Workplace by The Pittsburgh Post-Gazette...

23.09.25 - 08:18	SciBase receives initial order for clinical study from Castle Biosciences (PR Newswire)
	STOCKHOLM, Sept. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has received the initial order for a clinical study under the collaboration with Castle Biosciences. The......

20.09.25 - 03:01	Insiderhandel: Pres. & Chief Exec. Officer verkauft Aktien von Castle Biosciences im Wert von 29419 USD (Insiderkauf)
	Maetzold, Derek J. - Vorstand - Tag der Transaktion: 2025-09-17...

17.09.25 - 13:03	Castle Biosciences Named One of Newsweek′s America′s Greatest Companies 2025 (GlobeNewswire EN)
	Castle Biosciences has been included in the inaugural 2025 America's Greatest Companies list, published by Newsweek....

04.09.25 - 23:01	Insiderhandel: Pres. & Chief Exec. Officer verkauft Aktien von Castle Biosciences im Wert von 32042 USD (Insiderkauf)
	Maetzold, Derek J. - Vorstand - Tag der Transaktion: 2025-09-02...

30.08.25 - 01:01	Insiderhandel: Chief Operating Officer verkauft Aktien von Castle Biosciences im Wert von 669707 USD (Insiderkauf)
	Oelschlager, Kristen M. - Vorstand - Tag der Transaktion: 2025-08-27...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wenn du nur guten Willen hast, mein Sohn, so wirst du weise, und wenn du deinen Sinn darauf richtest, wirst du klug. - Altes Testament: Buch Jesus Sirach

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram